As more technologies emerge to diagnose and treat various physiological and health-related problems, Mike Moore sits down on this week’s episode to chat with Dr. Geoffrey Strange and Deon Strydom of Echo IQ. This revolutionary digital resource works to identify existing heart disease or conditions for future structural heart issues. With Dr. Strange as Echo IQ’s Chief Research and Strategy Officer and Deon Strydom at the head of the commercial side as Chief Commercial Officer, these two have worked tirelessly together to create and develop a product that can diagnose both efficiently and accurately. Tune in to today’s episode to learn more about how Echo IQ was built, their challenges along the way, their hope for the company's future, and how AI is changing the landscape of cardiovascular health. Notable Quotes“All of those parameters are collected on echocardiography. And because we’ve been able to bring all of that together, we’re able to truly see the multi-dimensional interrelationships in a way that we as humans attempt to do, but this is a uniform process. Happens the same every time. It’s not tired at the end of the day, you know? Equitable access to everybody.” – Dr. Strange (9:36)“One out of eight patients over the age of 65 have some form of structural heart disease, and if you take something like aortic stenosis like Professor Strange mentioned earlier, you have to keep in mind that there’s a 50% two-year survival rate, so you can see that there’s a real need to act really urgently. So that gives a bit of the size of the market.” – Deon (12:18)In This Episode(2:29) The spark behind Echo IQ (4:35) How Echo IQ was built and how it works(7:55) The software’s unique capabilities(11:52) Deon reveals the size of the market and patient care(19:03) How they acquired the data and how they worked to fit their software into the current market(22:28) Echo IQ’s customers and users in the healthcare industry(29:10) How AI can help patients with aortic stenosis(30:55) Echo IQ’s commercial model for the US (34:05) Dr. Strange and Deon share the challenges that may lie ahead for the companyOur GuestsDr. Geoffrey Strange – Chief Research and Strategy Officer – and Deon Strydom – Chief Commercial Officer – of Echo IQ are currently revolutionizing the way in which different forms of heart disease are diagnosed. As they work to further develop this technology and overcome obstacles related to this disease and the healthcare system as a whole, they are committed to moving into the future of cardiovascular health and treatment.
Resources & Links
LinkedIn: Mike Moore
LinkedIn: The Bleeding Edge of Digital Health